The efficacy of combined treatment with recombinant human tumor necrosis factor-α and 5-fluorouracil is dependent on the development of capillaries in tumor

European Journal of Cancer and Clinical Oncology

Volumn 26, Issue 2, 1990, Pages 93-99

  Manda, Toshitaka ^a   Nishigaki, Fusako ^a   Mukumoto, Sueo ^a   Masuda, Kikuo ^a   Nakamura, Takaaki ^a   Shimomura, Kyoichi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; FIBROSARCOMA; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FIBROSARCOMA; FLUOROURACIL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR;

EID: 0025272786     PISSN: 02775379     EISSN: None     Source Type: Journal    
DOI: 10.1016/0277-5379(90)90289-6     Document Type: Article

References (32)

1. An endotoxin-induced serum factor that causes necrosis of tumors
2. Human tumor necrosis factor: production, purification and characterization
3. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin
4. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons
5. Recombinant human tumor necrosis factor—II. Antitumor effect on murine and human tumors transplanted in mice
6. Recombinant human tumor necrosis factor-α: evidence of an indirect mode of antitumor activity
7. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro
8. Recombinant human tumor necrosis factor—I. Cytotoxic activity in vitro
9. Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed human and mouse cell lines
10. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1
11. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
12. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1
13. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells
14. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor
15. Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity
16. Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II
17. Anti-tumor effects of tumor necrosis factor in combination with chemotherapeutic agents
18. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages
19. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon
20. Combination tumor-immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice
21. Synergistic anti-proliferative activity of interleukin 1 and tumor necrosis factor
22. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice
23. Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia
24. Synergistic effects of recombinant human tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis
25. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors
26. Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors
27. Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-α in mice
28. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice
29. Recombinant human tumor necrosis factor-α: thrombus formation is a cause of antitumor activity
30. Antitumor effect of recombinant tumor necrosis factor-α against murine sarcomas at visceral sites: tumor size influences the response to therapy
31. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas
32. Tumor necrosis factor-α induces early morphologic and metabolic alterations in friend leukemia cell tumors and fibrosarcomas in mice